Hepatology APC and Open Access: Latest Public LWW Fee Schedule, Coverage, and Fit
Hepatology APC uses the latest public LWW fee schedule: $3,900 for both CC BY-NC-ND and CC BY. Coverage, metrics, and fit.
Readiness scan
APC budgeted? See what Hepatology reviewers are likely to push back on.
The fee is one decision. Getting through review is the harder one. Run the Free Readiness Scan with Hepatology as your target to see desk-rejection risk, likely reviewer concerns, and journal fit.
Quick answer: Hepatology APC is one of the cleaner pages to ground because the journal's official submission instructions expose a real fee schedule.
As of October 9, 2026, the journal's official Instructions for Authors list the 2026 APC at $3,900 for CC BY-NC-ND and $3,900 for CC BY. Hepatology remains a hybrid journal, so the subscription route is still $0 for the APC, although color figure charges can apply separately.
For the hub, see the Hepatology journal page.
Hepatology APC at a glance
Item | Current position |
|---|---|
Journal model | Hybrid |
2026 CC BY-NC-ND APC | $3,900 |
2026 CC BY APC | $3,900 |
Subscription route | $0 APC |
Color figure charge | $500 per page (whole or partial); avoided by removing all color |
Payment timing | After acceptance |
2024 impact factor | 18 |
5-year JIF | 16 |
JIF without self-cites | 15.2 |
JCI | 3.25 |
SJR 2024 | 5.557 |
H-index | 415 |
JCR rank | 7/147 |
If the fee looks manageable, the real risk is still editorial fit. A Hepatology desk-rejection risk check is the useful first step, not the payment workflow.
What the current official source actually says
The most useful verified source here is the journal's own official Editorial Manager instructions. Those instructions state:
- open access is optional
- the APC is charged on acceptance and should be paid within 30 days by the author, funding agency or institution
- payment must be completed for the article to publish OA
- the 2026 APC listed there is:
- $3,900 for CC BY-NC-ND
- $3,900 for CC BY
That matters because many generic APC aggregators still float older or wrong Hepatology numbers.
It also resolves the publisher question for this page: the verified OA workflow is being handled through the journal's Wolters Kluwer and LWW pathway, not through a Wiley-style hybrid charge flow.
Metrics context behind the APC
Metric | Current figure | Why it matters |
|---|---|---|
JIF | 18 | Hepatology remains one of the strongest liver-owned journals |
5-year JIF | 16 | Long-run citation profile stays strong |
JIF without self-cites | 15.2 | The citation signal is clean, not self-cite driven |
JCI | 3.18 | Field-normalized performance is strong |
SJR | 5.557 | Prestige-weighted influence is high for a specialty journal |
H-index | 415 | Archive authority is deep |
JCR rank | 7/147 | Clear Q1 position in Gastroenterology and Hepatology |
The practical message is straightforward: Hepatology is not charging flagship-general-medicine money. It is charging a premium specialty-journal hybrid APC for a liver-owned title with real field authority.
Long-run trend table
The JCR page gives the current JIF. For longer directional context, the open Scopus-based impact-score series is the cleanest stable trend line available.
Year | Scopus impact score |
|---|---|
2014 | 8.04 |
2015 | 8.08 |
2016 | 8.12 |
2017 | 7.22 |
2018 | 6.99 |
2019 | 8.08 |
2020 | 9.41 |
2021 | 9.42 |
2022 | 8.89 |
2023 | 7.92 |
2024 | 9.55 |
Directionally, the open citation signal is positive. Hepatology is up from 7.92 in 2023 to 9.55 in 2024 on the Scopus impact-score line. That fits the broader picture of a journal that still has strong liver-field ownership.
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
What authors actually need to decide
The real choices at Hepatology are:
Subscription route
- no APC
- still viable for authors without an immediate-OA mandate
Open-access route
- pay $3,900 for either CC BY-NC-ND or CC BY, using the 2026 schedule in the Instructions for Authors
- usually the right move when funder rules require immediate OA or a library agreement covers the bill
Coverage and waiver reality
- institutional or consortium support may reduce or remove the author bill
- exact eligibility is publisher-side and institution-specific
- the instructions say the APC can be paid by the author, a funding agency or an institution, so ask your library or funder about coverage
The useful planning rule is simple: treat the verified public schedule as the default, then check your library before assuming you will actually pay it.
How Hepatology compares with nearby liver and GI options
Journal | OA cost posture | 2024 citation profile | Practical comparison |
|---|---|---|---|
Hepatology | Hybrid, $3,900 under the 2026 schedule for either license | IF 15.8, SJR 5.557 | Strong liver-owned flagship lane |
Journal of Hepatology | Hybrid, usually higher | Higher top-line IF | Better if the manuscript is cleaner for EASL readership |
Gut | Hybrid premium band | Stronger broad GI profile | Better when the story is broader GI, not purely liver-owned |
Clinical Gastroenterology and Hepatology | Hybrid | Lower prestige but strong practice relevance | Better for more practice-facing work |
Hepatology Communications | Fully OA sister lane | Lower citation tier | Cleaner OA path when the flagship bar is not realistic |
The important point is that Hepatology is not a generic GI prestige purchase. If the paper is truly liver-owned, the APC is easier to justify. If the paper only touches hepatology at the edges, the fee is the wrong thing to focus on.
What we see in pre-submission review work on Hepatology manuscripts
In our pre-submission review work, the APC becomes a mistake only after the fit mistake has already happened.
The repeat pattern is:
- a manuscript with a real liver angle
- but not enough liver ownership in the evidence package
- plus a submission plan driven by the journal name rather than the journal audience
That is why Hepatology APC planning should come after one harder question: would a hepatologist immediately recognize the manuscript as liver-first? If the answer is shaky, a quick Hepatology submission readiness check is worth more than another hour comparing APC tables.
Submit if / Think twice if
Submit and consider the APC worthwhile if:
- the liver question is central and visible from page one
- the manuscript is competitive for a flagship liver journal
- your institution or funder can absorb the fee
- immediate OA has a real compliance or dissemination benefit
Think twice if:
- the liver framing is thinner than the cover letter suggests
- the manuscript is mostly a broader GI or translational story
- you would be paying personally without a mandate
- the cleaner owner journal is Hepatology Communications or another non-flagship venue
Practical verdict
For Hepatology APC, the current verified public answer is stronger than the old approximation-heavy version:
- hybrid journal
- $0 subscription route
- 2026 schedule verified in the journal instructions:
- $3,900 for CC BY-NC-ND
- $3,900 for CC BY
That is a real planning number. The only reason to ignore it is if your institution covers the bill.
Frequently asked questions
As of October 9, 2026, the official Hepatology Instructions for Authors list the 2026 APC at $3,900 for CC BY-NC-ND and $3,900 for CC BY.
No. Hepatology is a hybrid journal. Authors can still publish through the subscription route at $0 and only pay if they opt for open access.
The open-access route runs through the journal's Wolters Kluwer open-access pathway: authors complete a License to Publish online, and the APC is charged on acceptance and due within 30 days.
Sometimes. Coverage depends on publisher-side arrangements and institutional eligibility, so authors need to check with their library rather than assume general publisher coverage.
It makes the most sense when a funder or institution covers the bill and the paper is strong enough for Hepatology's liver-specific flagship editorial lane.
Sources
Free guide
The list price is rarely the price you pay.
Waivers, funder agreements and institutional deals move it, and the deadline for most of them is submission, after which there is no appeal. Every figure in the guide was read off the publisher or funder page that sets it, on the date shown, and each one is linked at the end.
Before you upload
Want the full picture on Hepatology?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Private API processing. Your manuscript is not used to train models.
Put the guidance to work
Build a journal decision from more than one signal.
Use comparison data as a starting point, then confirm the live source that governs the actual submission decision.
Where to go next
Start here
Same journal, next question
- Hepatology Submission Guide: Scope, Format & Tips
- Is Hepatology a Good Journal? The AASLD Liver Flagship
- Hepatology Impact Factor 2026: 18, Q1, Rank 7/153
- Hepatology Acceptance Rate: What Authors Can Use
- Hepatology 'Under Review': What Each Status Means and When to Expect a Decision
- Rejected from Hepatology? The 7 Best Journals to Submit Next